Bariatric surgery has been increasingly used in patients with obesity, and is an effective way to help aid glycemic control. It has been suggested that changing how nutrients are presented to the duodenum is one reason why improvements are seen after bariatric surgery. Importantly, this alteration does not appear to lead to malabsorption of nutrients. […]
The collaboration enables a seamless data transfer of data from Dexcom’s CGM (continuous glucose monitoring) devices into DreaMed Advisor, a platform designed to assist healthcare professionals in the optimization of patient-specific insulin therapy for people with diabetes by analyzing information from CGM, self-monitoring blood glucose, and insulin delivery devices. Read more
Telemedicine is the use of information and communication technologies, such as the Internet, to help with patient care, and can include diagnosing or even treating the patient. It has already been put to use in treating some chronic conditions, and studies have found telemedicine showed a benefit in helping patients with their blood sugar control. […]
The US Department of Veterans Affairs (VA) has partnered with Silicon Valley startup Virta Health Corp. to test the popular “Keto” diet. Virtua claims the diet provides treatment “clinically-proven to safely and sustainably reverse type 2 diabetes” without medication or surgery, but some diabetes experts are skeptical and find the company’s partnership with the federal […]
New research suggests that community-based diabetes screening in barbershops owned by black people may help diagnose diabetes in black men, and assist them in coping with a diabetes diagnosis. Data has shown diabetes complications to be disproportionately high among black men compared with other ethnic groups. Read more
The link between cancer and diabetes is not entirely understood, but biological mechanisms linking diabetes and cancer include hyperglycemia, hyperinsulinemia, oxidative stress, dysregulations of sex hormones, and chronic inflammation. Although there is a known risk for cancer for people with diabetes, routine checks are still absent, and the potential of early detection and treatment of […]
US pharmacy chain CVS has announced a new program, RxZERO, which will provide diabetes medications with no co-pay. According to research by CVS, people with diabetes typically spend around $467 out-of-pocket for brand name prescriptions every year, with some (12%) spend up to $1,000 on diabetes medications. Read more
Reducing the high cost of insulin in the United States will require multiple changes to the current complex drug pricing system, Mayo Clinic hematologist S. Vincent Rajkumar, MD, argues in a new commentary, The High Cost of Insulin in the United States: An Urgent Call to Action. Read more
The U.S. Food and Drug Administration (FDA) has approved Fiasp (insulin aspart injection; Novo Nordisk), a rapid-acting human insulin analog, for use in children with diabetes. Fiasp has an additional ingredient, niacinamide, which increases absorption speed, and was previously approved for use in adults and in insulin pumps. Read more
If you have diabetes and are considering getting a tattoo, there are some things to be aware of to ensure you have a positive experience. Blood pressure and blood sugar levels can both rise while a tattoo is being applied, and high blood sugar levels can also complicate the healing process, increasing the risk of […]
According to the International Diabetes Foundation, an estimated 425 million people currently have diabetes, a number that is expected to increase to more than 600 million within a generation, and annual diabetes deaths now outnumber those from HIV/AIDS and breast cancer, combined. Read more
Researchers report that anxiety affects about 40% of Americans with diabetes, a prevalence more than twice as high as in the general U.S. population. The stress and complexity of managing diabetes, as well as fear of hypoglycemia, may play a role. Read more
Diabulemia is a term used to describe an eating disorder in diabetes patients in which the patient deliberately restricts insulin in order to lose weight; medical professionals may also use the term ED-DMT1, Eating Disorder-Diabetes Mellitus Type 1, which is used to refer to any type of eating disorder in combination with with type 1 […]
A new trial has found that premature babies may be more likely to develop diabetes at some point in their life than other babies. The researchers found that babies born before 37 weeks are 21% more likely to develop type 1 diabetes and 26% more likely to develop type 2 diabetes within the study time […]
The physical damage to the body caused by diabetes, and concern about growing rates of diabetes in children and teens, are widely discussed. But there are also some serious psychological effects to consider, and whether these are addressed might make the difference in whether someone is successful in managing their diabetes or not. Read more
The circadian clocks inside the body’s cells that help regulate timing of many body functions and control cardiovascular disease risks within a 24-hour day appear to be affected by high glucose in obesity. “We know that high glucose impairs circadian clock functions, but now we want to know [if] by fixing the clock can we […]
Researchers may be only beginning to understand how Alzheimer’s disease and type 2 diabetes could be linked. Deciphering the connection could lead to earlier Alzheimer’s diagnosis and better treatments for both diseases. The connection involves how the brain metabolizes blood sugar and the factors that influence that process, including diet, sleep, and cardiovascular health. […]
Sexual dysfunction is common in patients with diabetes: over half of men with diabetes have erectile dysfunction (ED), which is defined as failure to obtain and maintain an erection sufficient for sexual activity, or decreased erectile turgidity on 75% of sexual occasions, and lasting for at least six months. Read more
A new study further reinforces that there is an association of type 2 diabetes and depression with heart risk. Patients who have depression and diabetes are at higher risk for all-cause mortality and cardiovascular mortality compared to diabetes patients who do not have depression. Read more
Abbott and Sanofi, two of the largest companies in diabetes treatment, are partnering to develop tools that will integrate Abbott’s blood sugar tracking and Sanofi’s insulin delivery technologies, with the goal of creating a “connected device experience” for patients. Read more